Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACT: rTMS for Apathy in Dementia
NCT05561205Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Feb 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of methylphenidate in apathy (2 arms), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Neuropsychiatric Inventory-apathy at 2 weeks. Started Feb 2023; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
apathy
Beyond the preview
Go deeper on NCT05561205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05561205.